In summary, we revealed a novel mechanism by which lncRNA Airn prevented IMP2 degradation and played a synergetic role with IMP2 in promoting p53 mRNA stabilization in an m6A modification-dependent manner, thus, alleviating myocardial fibrosis in DCM. The gene discussed is TP53; the disease is familial dilated cardiomyopathy.